ERβ as Mediator of Estrogen Signaling in Inflammatory Breast Cancer | Oncotarget

Posted by

Oncotarget

Oncotarget published this editorial on June 12, 2023 in Volume 14, entitled, “ERβ as Mediator of Estrogen Signaling in Inflammatory Breast Cancer" by Harika Nagandla and Christoforos Thomas from the Houston Methodist Research Institute, Houston Methodist Neal Cancer Center, Houston, TX. DOI - https://doi.org/10.18632/oncotarget.28425 Correspondence to - Christoforos Thomas - cthomas3@houstonmethodist.org Sign up for free Altmetric alerts about this article - https://oncotarget.altmetric.com/details/email_updates?id=10.18632%2Foncotarget.28425 Subscribe for free publication alerts from Oncotarget - https://www.oncotarget.com/subscribe/ Keywords - inflammatory breast cancer, IBC, ERβ, metastasis, actin based cell migration About Oncotarget Oncotarget is a primarily oncology-focused, peer-reviewed, open access journal. Papers are published continuously within yearly volumes in their final and complete form, and then quickly released to Pubmed. On September 15, 2022, Oncotarget was accepted again for indexing by MEDLINE. Oncotarget is now indexed by Medline/PubMed and PMC/PubMed. To learn more about Oncotarget, please visit https://www.oncotarget.com and connect with us: SoundCloud - https://soundcloud.com/oncotarget Facebook - https://www.facebook.com/Oncotarget/ Twitter - https://twitter.com/oncotarget Instagram - https://www.instagram.com/oncotargetjrnl/ YouTube - https://www.youtube.com/@OncotargetJournal LinkedIn - https://www.linkedin.com/company/oncotarget Pinterest - https://www.pinterest.com/oncotarget/ Reddit - https://www.reddit.com/user/Oncotarget/ Media Contact MEDIA@IMPACTJOURNALS.COM 18009220957